Meta-analysis models cost-effectiveness of IV alteplase plus thrombectomy for large vessel occlusion stroke.
Adding alteplase to stroke surgery is cost-effective when treatment starts within 170 minutes.
This meta-analysis models cost-effectiveness using individual patient data from 6 trials involving 2,268 patients across 16 countries. It ev…
Adding clot-busting medicine to stroke surgery saves money and improves value when treatment starts within 170 minutes, but benefits fade af…
Non-randomized trial of Zoom system for LVO stroke reperfusion exceeds performance goals
Can a new stroke device clear deadly clots faster and more often?
This is a prospective, multicenter, non-randomized investigational device exemption trial in 260 adults with anterior circulation LVO stroke…
A new stroke device cleared deadly clots in 83% of patients within three tries, restoring blood flow in just 19 minutes.
Earlier endovascular therapy within 24 hours associated with smaller infarct and better outcomes in LVO stroke.
Does waiting longer for stroke treatment cause more brain damage and worse recovery?
This prospective cohort study evaluated 216 patients with anterior circulation large-vessel occlusion stroke treated with endovascular thera…
Waiting longer for stroke treatment causes more dead brain tissue and leaves fewer patients able to live independently after 90 days.
Direct Transfer to Angiography Suite Shows No Benefit, Higher Hemorrhage Risk in Severe Stroke
Does rushing stroke patients straight to treatment improve their recovery?
A randomized trial in 115 adults with acute severe stroke from large vessel occlusion compared direct transfer to angiography suite (DTAS) w…
Skipping the CT scan to rush stroke patients straight to treatment did not improve recovery and increased the risk of serious brain bleeding…